Document is current

Any future updates will be listed below

Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study

Crossref DOI link: https://doi.org/10.1038/eye.2017.187

Published Online: 2017-09-22

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark